CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1.

Blood. 1995 May 1;85(9):2308-14. Unique Identifier : AIDSLINE MED/95244849
Semenzato G; Agostini C; Ometto L; Zambello R; Trentin L; Chieco-Bianchi L; De Rossi A; Padua University School of Medicine, Institutes of Clinical; Medicine and Oncology, Italy.


Abstract: Human immunodeficiency virus-1 (HIV-1) infection of CD8+ lymphocytes has been described in several in vitro culture systems, but whether CD8+ cells are a target and also serve as a reservoir for infection in vivo as yet is unknown. We addressed this issue in patients with acquired immunodeficiency syndrome (AIDS)-related lower respiratory tract chronic inflammation, which is characterized by a massive influx of CD8+ HIV-1-specific cytotoxic T lymphocytes (CTL). Proviral load in lung T lymphocytes and their subpopulations was evaluated by using the DNA-polymerase chain reaction (PCR) technique on cells retrieved by bronchoalveolar lavage. To avoid the possibility that the presence of HIV-1 DNA could be caused by contaminating CD4+ cells, serial dilutions of highly purified CD8+ cells were also analyzed by PCR. Our findings showed that lung CD8+ cells harbor and express HIV-1. To explore the possible mechanisms leading to pulmonary CD8+ lymphocyte infection, we evaluated CD4 gene expression on highly purified CD8+ cells by means of reverse transcriptase PCR. Despite the lack of membrane CD4 reactivity, we could show that CD8+ cells may express CD4 RNA. Coinfection of lung CD8+ cells harboring proviral HIV-1 sequences by viral agents capable of inducing CD4 expression (ie, HHV-6) was not detected. Our data indicate that not only CD4+ T lymphocytes and macrophages, but also CD8+ cells, may represent a target and/or a reservoir for HIV-1 in vivo, and suggest that lung CD8+ lymphocytes could derive from precursors equipped with enough CD4 molecules to become HIV-1 permissive. Aside from the cell-to-cell contact between activated HIV-1 specific CTL and relevant targets, the infection of precursors could represent an additional mechanism accounting for the infection of pulmonary CD8+ cells and their functional impairment.
Keywords: Acquired Immunodeficiency Syndrome/PATHOLOGY/*VIROLOGY Adult Antigens, CD4/BIOSYNTHESIS Bronchoalveolar Lavage Fluid Cell Separation Cells, Cultured CD8-Positive T-Lymphocytes/METABOLISM/*VIROLOGY DNA, Viral/ANALYSIS Female Human HIV-1/*ISOLATION & PURIF/PHYSIOLOGY Lung/PATHOLOGY/*VIROLOGY Macrophages, Alveolar/VIROLOGY Male Middle Age Models, Biological Polymerase Chain Reaction Proviruses/ISOLATION & PURIF RNA, Messenger/ANALYSIS Support, Non-U.S. Gov't T-Lymphocytes, Cytotoxic/METABOLISM/VIROLOGY Virus Replication JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/pathology/KWDvirologyadultantigens,cd4/biosynthesisbronchoalveolarlavagefluidcellseparationcells,culturedcd8-positivet-lymphocytes/metabolism/KWDvirologydna,viral/analysisfemalehumanhiv-1/KWDisolation&purif/physiologylung/pathology/KWDvirologymacrophages,alveolar/virologymalemiddleagemodels,biologicalpolymerasechainreactionproviruses/isolation&purifrna,messenger/analysissupport,non-uKWDsKWDgov'tt-lymphocytes,cytotoxic/metabolism/virologyvirusreplicationjournalarticle
950830
M9580950

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .